The Effects of Donor Age on Organ Transplants: A Review and Implications for Aging Research

Overview

Journal Exp Gerontol

Specialty Geriatrics

Date 2018 Jun 24

PMID 29935294

Citations 30

Authors

Jose Carlos Dayoub

Franco Cortese

Andreja Anzic

Tjasa Grum

Joao Pedro de Magalhaes

Affiliations

Soon will be listed here.

Abstract

Despite the considerable amount of data available on the effect of donor age upon the outcomes of organ transplantation, these still represent an underutilized resource in aging research. In this review, we have compiled relevant studies that analyze the effect of donor age in graft and patient survival following liver, kidney, pancreas, heart, lung and cornea transplantation, with the aim of deriving insights into possible differential aging rates between the different organs. Overall, older donor age is associated with worse outcomes for all the organs studied. Nonetheless, the donor age from which the negative effects upon graft or patient survival starts to be significant varies between organs. In kidney transplantation, this age is within the third decade of life while the data for heart transplantation suggest a significant effect starting from donors over age 40. This threshold was less defined in liver transplantation where it ranges between 30 and 50 years. The results for the pancreas are also suggestive of a detrimental effect starting at a donor age of around 40, although these are mainly derived from simultaneous pancreas-kidney transplantation data. In lung transplantation, a clear effect was only seen for donors over 65, with negative effects of donor age upon transplantation outcomes likely beginning after age 50. Corneal transplants appear to be less affected by donor age as the majority of studies were unable to find any effect of donor age during the first few years posttransplantation. Overall, patterns of the effect of donor age in patient and graft survival were observed for several organ types and placed in the context of knowledge on aging.

Citing Articles

Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances.

Jiang Q, Liu J, Huang S, Wang X, Chen X, Liu G Signal Transduct Target Ther. 2025; 10(1):76.

PMID: 40059211 PMC: 11891338. DOI: 10.1038/s41392-025-02145-7.

A narrative review on the psychosocial domains of the impact of organ transplantation.

Aderinto N, Olatunji G, Kokori E, Ogieuhi I, Moradeyo A, Woldehana N Discov Ment Health. 2025; 5(1):20.

PMID: 39992446 PMC: 11850674. DOI: 10.1007/s44192-025-00148-y.

Airway epithelium in lung transplantation: a potential actor for post-transplant complications?.

Milesi J, Gras D, Chanez P, Coiffard B Eur Respir Rev. 2024; 33(174).

PMID: 39603662 PMC: 11600126. DOI: 10.1183/16000617.0093-2024.

The combinatorial effect of age and biological sex on alloimmunity and transplantation outcome.

Martin F, Xiao Y, Welten V, Nakamori K, Gizlenci M, Zhou H Front Transplant. 2024; 2:1325232.

PMID: 38993871 PMC: 11235293. DOI: 10.3389/frtra.2023.1325232.

Sex difference and immunosenescence affect transplantation outcomes.

Maenosono R Front Transplant. 2024; 2:1235740.

PMID: 38993850 PMC: 11235384. DOI: 10.3389/frtra.2023.1235740.

References

Johnson R, Bradbury L, Martin K, Neuberger J . Organ donation and transplantation in the UK-the last decade: a report from the UK national transplant registry. Transplantation. 2013; 97 Suppl 1:S1-S27. DOI: 10.1097/01.TP.0000438215.16737.68. View

De Fijter J, Mallat M, Doxiadis I, Ringers J, Rosendaal F, Claas F . Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol. 2001; 12(7):1538-1546. DOI: 10.1681/ASN.V1271538. View

Waiser J, Schreiber M, Budde K, Fritsche L, Bohler T, Hauser I . Age-matching in renal transplantation. Nephrol Dial Transplant. 2000; 15(5):696-700. DOI: 10.1093/ndt/15.5.696. View

Stehlik J, Edwards L, Kucheryavaya A, Benden C, Christie J, Dipchand A . The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report--2012. J Heart Lung Transplant. 2012; 31(10):1052-64. DOI: 10.1016/j.healun.2012.08.002. View

Nagji A, Hranjec T, Swenson B, Kern J, Bergin J, Jones D . Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation. Ann Thorac Surg. 2010; 90(1):168-75. PMC: 3033784. DOI: 10.1016/j.athoracsur.2010.03.043. View

Yusen R, Edwards L, Kucheryavaya A, Benden C, Dipchand A, Goldfarb S . The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report--2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant. 2015; 34(10):1264-77. DOI: 10.1016/j.healun.2015.08.014. View

Adam R, Karam V, Delvart V, OGrady J, Mirza D, Klempnauer J . Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012; 57(3):675-88. DOI: 10.1016/j.jhep.2012.04.015. View

Gal R, Dontchev M, Beck R, Mannis M, Holland E, Kollman C . The effect of donor age on corneal transplantation outcome results of the cornea donor study. Ophthalmology. 2008; 115(4):620-626.e6. PMC: 2810523. DOI: 10.1016/j.ophtha.2008.01.003. View

Lass J, Gal R, Dontchev M, Beck R, Kollman C, Dunn S . Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results. Ophthalmology. 2008; 115(4):627-632.e8. PMC: 2959119. DOI: 10.1016/j.ophtha.2008.01.004. View

10.

Demetris A, Murase N, Starzl T, Fung J . Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention. Graft (Georget Tex). 2011; 1(2):52-59. PMC: 3091028. View

11.

Mannis M, Holland E, Gal R, Dontchev M, Kollman C, Raghinaru D . The effect of donor age on penetrating keratoplasty for endothelial disease: graft survival after 10 years in the Cornea Donor Study. Ophthalmology. 2013; 120(12):2419-2427. PMC: 3885822. DOI: 10.1016/j.ophtha.2013.08.026. View

12.

Marino I, Doyle H, Aldrighetti L, Doria C, McMichael J, Gayowski T . Effect of donor age and sex on the outcome of liver transplantation. Hepatology. 1995; 22(6):1754-62. PMC: 2965620. View

13.

Manousou P, Samonakis D, Cholongitas E, Patch D, OBeirne J, Dhillon A . Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy. Liver Transpl. 2009; 15(12):1783-91. DOI: 10.1002/lt.21907. View

14.

Conboy M, Conboy I, Rando T . Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity. Aging Cell. 2013; 12(3):525-30. PMC: 4072458. DOI: 10.1111/acel.12065. View

15.

Scioli M, Bielli A, Arcuri G, Ferlosio A, Orlandi A . Ageing and microvasculature. Vasc Cell. 2014; 6:19. PMC: 4169693. DOI: 10.1186/2045-824X-6-19. View

16.

Rifai K, Sebagh M, Karam V, Saliba F, Azoulay D, Adam R . Donor age influences 10-year liver graft histology independently of hepatitis C virus infection. J Hepatol. 2004; 41(3):446-53. DOI: 10.1016/j.jhep.2004.05.013. View

17.

Armitage W, Jones M, Zambrano I, Carley F, Tole D . The suitability of corneas stored by organ culture for penetrating keratoplasty and influence of donor and recipient factors on 5-year graft survival. Invest Ophthalmol Vis Sci. 2013; 55(2):784-91. DOI: 10.1167/iovs.13-13386. View

18.

Hoofnagle J, Lombardero M, Zetterman R, Lake J, Porayko M, Everhart J . Donor age and outcome of liver transplantation. Hepatology. 1996; 24(1):89-96. DOI: 10.1002/hep.510240116. View

19.

Alexander J, Vaughn W . The use of "marginal" donors for organ transplantation. The influence of donor age on outcome. Transplantation. 1991; 51(1):135-41. DOI: 10.1097/00007890-199101000-00021. View

20.

Potapov E, Loebe M, Hubler M, Musci M, Hummel M, Weng Y . Medium-term results of heart transplantation using donors over 63 years of age. Transplantation. 2000; 68(12):1834-8. DOI: 10.1097/00007890-199912270-00002. View